The problem we’re trying to solve
Discover how Protas is tackling the burden of common disease worldwide through smarter trials.
The latest in smarter trials
As a not-for-profit, our mission is to enable whole-system change in clinical trials. This means sharing our approach and knowledge with our community. From news about Protas, our partnerships and trials, to advice and guidance, discover more about our world.
Smarter trials for better health
Protas is fixing the market failure which drives the declining development of treatments for common diseases.
The people behind Protas
Our people bring unparalleled knowledge and experience in our pursuit of smarter clinical trials.
Good clinical trials need good guidance
Protas and the Good Clinical Trials Collaborative are enabling good clinical trials to take place.
Protas launches early market engagement for unified clinical trials management platform
Protas publishes a prior information notice for provision of cloud-based clinical trials management platform.
Protas welcomes four new starters
To drive forward its mission of reducing barriers in the development of treatments for common diseases, Protas welcomes new team.
Protas launches with Sanofi as its first partner
The new not-for-profit designing and delivering smarter clinical trials has launched with the biopharma Sanofi as first partner.
Protas welcomes the Good Clinical Trials Collaborative
Protas becomes the new host organisation for the Good Clinical Trials Collaborative.
Podcast: Protas on BBC Inside Health
Prof Sir Martin Landray featured on BBC show that discusses topical health issues which people struggle to understand.
Protas interviewed by The Lancet for new Research Focus
The medical journal has published an in-depth article exploring Protas’ work and mission.
Procurement: unified clinical trials management platform
Protas has recently released a contract notice for a unified clinical trials management platform (UCTMP).
Clinical Trials Day: Prof Sir Martin Landray, Chief Executive Officer
Sir Martin shares his experience with clinical trials and what they mean to him.